Strides Pharma Science Limited

Strides Pharma schedules an earnings call for May 18, 2026, to discuss its audited Q4 and FY26 results. Managing Director Badree Komandur and Group CFO Vikesh Kumar will host the conference call for i

Strides Pharma board meeting scheduled for May 18, 2026 to approve FY2026 audited financial results and consider final dividend. Trading window for designated persons closed since April 1, 2026 and wi